Ultrasensitive measurement of huntingtin protein in cerebrospinal fluid demonstrates increase with Huntington disease stage and decrease following brain huntingtin suppression

Amber L. Southwell, Stephen E P Smith, Tessa R. Davis, Nicholas S. Caron, Erika B. Villanueva, Yuanyun Xie, Jennifer A. Collins, Min Li Ye, Aaron Sturrock, Blair R. Leavitt, Adam G. Schrum, Michael R. Hayden

Research output: Contribution to journalArticle

34 Scopus citations

Abstract

Quantitation of huntingtin protein in the brain is needed, both as a marker of Huntington disease (HD) progression and for use in clinical gene silencing trials. Measurement of huntingtin in cerebrospinal fluid could be a biomarker of brain huntingtin, but traditional protein quantitation methods have failed to detect huntingtin in cerebrospinal fluid. Using micro-bead based immunoprecipitation and flow cytometry (IP-FCM), we have developed a highly sensitive mutant huntingtin detection assay. The sensitivity of huntingtin IP-FCM enables accurate detection of mutant huntingtin protein in the cerebrospinal fluid of HD patients and model mice, demonstrating that mutant huntingtin levels in cerebrospinal fluid reflect brain levels, increasing with disease stage and decreasing following brain huntingtin suppression. This technique has potential applications as a research tool and as a clinical biomarker.

Original languageEnglish (US)
Article number12166
JournalScientific Reports
Volume5
DOIs
StatePublished - Jul 15 2015

    Fingerprint

ASJC Scopus subject areas

  • General

Cite this

Southwell, A. L., Smith, S. E. P., Davis, T. R., Caron, N. S., Villanueva, E. B., Xie, Y., Collins, J. A., Li Ye, M., Sturrock, A., Leavitt, B. R., Schrum, A. G., & Hayden, M. R. (2015). Ultrasensitive measurement of huntingtin protein in cerebrospinal fluid demonstrates increase with Huntington disease stage and decrease following brain huntingtin suppression. Scientific Reports, 5, [12166]. https://doi.org/10.1038/srep12166